PubRank

Ryosuke Amano

Author PubWeight™ 28.08‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Gastric metastasis from renal cell carcinoma with gastrointestinal bleeding: a case report and review of the literature. Int Surg 2014 1.14
2 Vitamin D receptor expression is associated with colon cancer in ulcerative colitis. Oncol Rep 2009 1.08
3 HER2 overexpression correlates with survival after curative resection of pancreatic cancer. Cancer Sci 2009 1.08
4 Prognostic value of preoperative inflammation-based prognostic scores in patients with stage IV colorectal cancer who undergo palliative resection of asymptomatic primary tumors. Anticancer Res 2013 1.02
5 Low nutritional prognostic index correlates with poor survival in patients with stage IV colorectal cancer following palliative resection of the primary tumor. World J Surg 2014 0.96
6 The impact of combined thoracoscopic and laparoscopic surgery on pulmonary complications after radical esophagectomy in patients with resectable esophageal cancer. Anticancer Res 2014 0.94
7 IGF-1 receptor and IGF binding protein-3 might predict prognosis of patients with resectable pancreatic cancer. BMC Cancer 2013 0.91
8 Chemokine receptor CCR7 expression correlates with lymph node metastasis in pancreatic cancer. Oncology 2008 0.91
9 In vitro and in vivo evidence that a combination of lapatinib plus S-1 is a promising treatment for pancreatic cancer. Cancer Sci 2009 0.90
10 Successful resection of esophageal cancer with right aortic arch by video-assisted thoracoscopic surgery: a case report. Anticancer Res 2013 0.90
11 RNA interference suppression of mucin 5AC (MUC5AC) reduces the adhesive and invasive capacity of human pancreatic cancer cells. J Exp Clin Cancer Res 2010 0.89
12 Elevated preoperative serum C-reactive protein levels are associated with poor survival in patients with colorectal cancer. Hepatogastroenterology 2015 0.89
13 HER3 overexpression as an independent indicator of poor prognosis for patients with curatively resected pancreatic cancer. Oncology 2011 0.87
14 Thoracoscopic esophagectomy in the prone position versus in the lateral position for patients with esophageal cancer: a comparison of short-term surgical results. Surg Laparosc Endosc Percutan Tech 2014 0.86
15 VEGF-A/VEGFR-2 signaling plays an important role for the motility of pancreas cancer cells. Ann Surg Oncol 2011 0.86
16 Combination therapy of S-1 with selective cyclooxygenase-2 inhibitor for liver metastasis of colorectal carcinoma. Anticancer Res 2008 0.83
17 Identification of HLA-A*0201- and A*2402-restricted epitopes of mucin 5AC expressed in advanced pancreatic cancer. Pancreas 2011 0.83
18 [Successful treatment of locally advanced squamous cell carcinoma of the esophagus by combination chemotherapy with 5-fluorouracil plus nedaplatin following tracheal stent tube placement-a case report]. Gan To Kagaku Ryoho 2013 0.82
19 Prognostic predictive values of gemcitabine sensitivity-related gene products for unresectable or recurrent biliary tract cancer treated with gemcitabine alone. World J Surg Oncol 2013 0.82
20 Predictive factors for change of diabetes mellitus status after pancreatectomy in preoperative diabetic and nondiabetic patients. J Gastrointest Surg 2014 0.81
21 Impact of preoperative diabetes mellitus on clinical outcome after pancreatectomy. Int J Surg 2013 0.81
22 Tumor budding and E-cadherin expression are useful predictors of nodal involvement in T1 esophageal squamous cell carcinoma. Anticancer Res 2013 0.80
23 [A case of liver metastasis of mixed acinar-endocrine carcinoma treated with various loco-regional cancer therapies]. Gan To Kagaku Ryoho 2008 0.80
24 Predictive value of expression of ERCC 1 and GST-p for 5-fluorouracil/oxaliplatin chemotherapy in advanced colorectal cancer. Hepatogastroenterology 2012 0.80
25 Portal vein stenting to treat portal vein stenosis in a patient with malignant tumor and gastrointestinal bleeding. Int Surg 2014 0.80
26 Laparoscopic resection of periadrenal paraganglioma: a report of 2 cases. Surg Laparosc Endosc Percutan Tech 2008 0.79
27 In vitro effects of lapatinib with gemcitabine for pancreatic cancer cells. Hepatogastroenterology 2013 0.78
28 Significance of phospho-vascular endothelial growth factor receptor-2 expression in pancreatic cancer. Cancer Sci 2010 0.78
29 Biochemical characterization of the water-soluble squalene synthase from Methylococcus capsulatus and the functional analyses of its two DXXD(E)D motifs and the highly conserved aromatic amino acid residues. FEBS J 2014 0.78
30 [A Case of Metastatic Lung Cancer from Colon Cancer with a Long Partial Response with Regorafenib Treatment]. Gan To Kagaku Ryoho 2016 0.77
31 Successful resection of esophageal carcinoma with aberrant right subclavian artery using video-assisted thoracoscopic surgery: report of two cases. Anticancer Res 2014 0.77
32 [A case of emphysematous cholecystitis during the course of chemotherapy for gastric cancer]. Gan To Kagaku Ryoho 2013 0.77
33 Clinical and pathological features of five-year survivors after pancreatectomy for pancreatic adenocarcinoma. World J Surg Oncol 2014 0.76
34 MUC1 and HER2 might be associated with invasive phenotype of intraductal papillary mucinous neoplasm. Hepatogastroenterology 2013 0.76
35 Plasma pharmacokinetics after combined therapy of gemcitabine and oral S-1 for unresectable pancreatic cancer. J Exp Clin Cancer Res 2010 0.75
36 Early gastric cancer with suspected brain metastasis arising eight years after curative resection: a case report. BMC Res Notes 2014 0.75
37 The outcome of surgical treatment for elderly patients with gastric carcinoma. J Surg Oncol 2015 0.75
38 [Effect of PSK on recurrence of stage II/III gastric cancer]. Gan To Kagaku Ryoho 2010 0.75
39 [A case of liver metastasis of pancreatic cancer that was resistant to S-1 and gemcitabine successfully treated by 5-FU and cisplatin hepatic arterial infusion]. Gan To Kagaku Ryoho 2010 0.75
40 [A case of desmoid tumor and advanced sigmoid colon cancer with liver metastasis in familial adenomatous polyposis (FAP)]. Gan To Kagaku Ryoho 2014 0.75
41 [Our experience of the treatment with XELOX±Bevacizumab for unresectable advanced colorectal cancer]. Gan To Kagaku Ryoho 2011 0.75
42 [Two cases of the primary small intestine cancer successfully treated with S-1 and UFT/LV therapy]. Gan To Kagaku Ryoho 2010 0.75
43 [Changes in tumor marker levels as a predictor of gemcitabine effect on patients with unresectable or recurrent pancreatic cancer]. Gan To Kagaku Ryoho 2005 0.75
44 [Salvage esophagectomy after definitive chemoradiation therapy]. Gan To Kagaku Ryoho 2011 0.75
45 [Locally recurrent case of gastric cancer with serosal invasion after four months of endoscopic submucosal dissection]. Gan To Kagaku Ryoho 2012 0.75
46 Comparison of prognosis between patients of pancreatic head cancer with and without obstructive jaundice at diagnosis. Int J Surg 2013 0.75
47 [A case of familial adenomatous polyposis presenting with thyroid cancer]. Gan To Kagaku Ryoho 2013 0.75
48 [A case of far-advanced gastric cancer successfully treated with S-1/paclitaxel/krestin immunochemotherapy, followed by curative resection]. Gan To Kagaku Ryoho 2012 0.75
49 [Three cases of giant rectal gastrointestinal stromal tumor]. Gan To Kagaku Ryoho 2011 0.75
50 Successful resection of esophageal carcinoma associated with double aortic arch: a case report. Anticancer Res 2012 0.75
51 [Effect of recombinant human soluble thrombomodulin in patients with solid carcinoma with DIC]. Gan To Kagaku Ryoho 2014 0.75
52 [Five cases of severe radiation pneumonitis after chemoradiotherapy for esophageal cancer]. Gan To Kagaku Ryoho 2013 0.75
53 [A case of long-term survival after undergoing S-1 based multidisciplinary therapy for liver metastasis of gastric cancer]. Gan To Kagaku Ryoho 2011 0.75
54 [Docetaxel with concurrent radiotherapy in patients with inoperable or relapsed oesophageal cancer]. Gan To Kagaku Ryoho 2010 0.75
55 SPan-1 is a useful prognostic marker for patients with stage IV gastric cancer who underwent palliative gastrectomy: a retrospective multivariate study. World J Surg 2013 0.75
56 [A Case of Small Intestinal Metastases from Renal Cell Carcinoma with Massive Bleeding]. Gan To Kagaku Ryoho 2015 0.75
57 [Significance of preoperative neutrophil-to-lymphocyte ratio as a predictor of prognosis in patients with stage IV colorectal cancer]. Gan To Kagaku Ryoho 2013 0.75
58 [A case of type 4 gastric cancer with positive peritoneal lavage cytology, which relapsed at the peritoneum at the time of seven years and eight months after resection]. Gan To Kagaku Ryoho 2010 0.75
59 [A Case of Demonstrating the Difficulties in Deciding How to Manage the Clinical Results after Rectal Resection]. Gan To Kagaku Ryoho 2015 0.75
60 Two-surgeon technique for liver transection using precoagulation by a soft-coagulation system and ultrasonic dissection. Hepatogastroenterology 2015 0.75
61 [Concurrent chemoradiotherapy with nedaplatin and 5-fluorouracil (5-fu) for locally advanced squamous cell carcinoma of the esophagus]. Gan To Kagaku Ryoho 2009 0.75
62 [hENT1, dCK, RRM, WFA-MY.1E12]. Nihon Rinsho 2015 0.75
63 [A case report of a stage IV gastric cancer patient with rapid progression of liver metastases induced by postoperative anastomotic leakage]. Gan To Kagaku Ryoho 2012 0.75
64 [A case of metastatic gastric cancer from breast cancer treated with proximal gastrectomy]. Gan To Kagaku Ryoho 2013 0.75
65 Impact of body mass index on surgical outcomes after esophagectomy for patients with esophageal squamous cell carcinoma. J Gastrointest Surg 2014 0.75
66 [Stage IV small cell esophageal carcinoma that responded to various chemotherapeutic regimens with relative longevity - a case report]. Gan To Kagaku Ryoho 2014 0.75
67 [A case of early gastric cancer with cervical lymph nodes recurrence 5 years after a curative resection]. Gan To Kagaku Ryoho 2012 0.75
68 [A case of locally advanced pancreatic cancer with hepatic artery invasion treated with neoadjuvant chemoradiotherapy]. Gan To Kagaku Ryoho 2013 0.75
69 [A case of lymph node recurrence occurring nine years after surgery for sigmoid colon cancer]. Gan To Kagaku Ryoho 2014 0.75
70 [Clinical Experience of S-1 and Oxaliplatin(SOX)as the First-Line Chemotherapy for Metastatic/Recurrent Gastric Cancer]. Gan To Kagaku Ryoho 2017 0.75